New Pesticide CRMs Released Specifically for Cannabis Labs in California and Similar States

Restek’s support for cannabis-testing labs continues to grow. This latest offering will help you meet the specific cannabis analysis needs of California set forth by the Bureau of Cannabis Control for regulated category I and II residual pesticide reporting—and of other states with similar regulations/programs.

Ideal for creating multipoint (5-point minimum suggested) calibration curves for GC- and LC-MS/MS, these six mixes of prepared stock standards also eliminate the need for in-house standards preparation. And, as with all certified reference materials (CRMs) manufactured and QC tested in Restek’s ISO-accredited labs, they will satisfy your ISO requirements.

Source: http://www.restek.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Restek Corporation. (2019, June 13). New Pesticide CRMs Released Specifically for Cannabis Labs in California and Similar States. AZoM. Retrieved on April 26, 2024 from https://www.azom.com/news.aspx?newsID=51422.

  • MLA

    Restek Corporation. "New Pesticide CRMs Released Specifically for Cannabis Labs in California and Similar States". AZoM. 26 April 2024. <https://www.azom.com/news.aspx?newsID=51422>.

  • Chicago

    Restek Corporation. "New Pesticide CRMs Released Specifically for Cannabis Labs in California and Similar States". AZoM. https://www.azom.com/news.aspx?newsID=51422. (accessed April 26, 2024).

  • Harvard

    Restek Corporation. 2019. New Pesticide CRMs Released Specifically for Cannabis Labs in California and Similar States. AZoM, viewed 26 April 2024, https://www.azom.com/news.aspx?newsID=51422.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.